Testing a new device that measures blood pressure in newborns with high blood pressure
Tests the Boppli device for measuring blood pressure in newborns in intensive care.
Plain-language title generated from the registry record
Registry title: Measurement of High Blood Pressure Using Boppli
Key facts
- Where
- Indianapolis, United StatesSee the site
Where in United States
- Riley Hospital for ChildrenIndianapolis, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Indiana University
- Trial code
- NCT07547917
- Record updated
- 11 June 2026
- Original description
This study evaluates a new, non-invasive device (Boppli™) that continuously measures blood pressure in newborn infants. The study compares Boppli measurements to standard blood pressure cuff measurements to determine how well the device works and whether it improves identification of high blood pressure in infants in the neonatal intensive care unit (NICU). The study also includes follow-up through 1 year of age to understand longer-term outcomes.Read full original descriptionShow less
Improving the Measurement of Neonatal High Blood Pressure Using the Boppli Device
This study evaluates a new, non-invasive device (Boppli™) that continuously measures blood pressure in newborn infants. The study compares Boppli measurements to standard blood pressure cuff measurements to determine how well the device works and whether it improves identification of high blood pressure in infants in the neonatal intensive care unit (NICU). The study also includes follow-up through 1 year of age to understand longer-term outcomes.
Inclusion: Admitted to the neonatal intensive care unit (NICU); Age 0 to 9 months at time of enrollment; Weight less than 5 kg; At risk for elevated blood pressure or with clinical concern for hypertension, -including but not limited to:; History of acute kidney injury or kidney disease; History of extracorporeal membrane oxygenation (ECMO); Parent or legal guardian able to provide informed consent.
Exclusion: Currently receiving extracorporeal membrane oxygenation (ECMO); Currently receiving any form of extracorporeal dialysis (e.g., continuous renal -replacement therapy); Congenital anomalies or clinical conditions that prevent placement of the Boppli™ device; Presence of a ventricular assist device; For Part 2 only: infants not expected to survive hospitalization.